03/09/2022
“There’s Still A Lot We Can Do”
PCF thanks Mr. Merzer for sharing his personal story, and for his dedication and support during the 100 Miles in March walking challenge. It is inevitable. It is part of life. It is how it all works. Sooner or later, preferably later and not frequently, bad news arrives. For me. Read More
03/08/2022
Highlights of ASCO GU 2022, Part 1
Combination treatments for metastatic disease Clinicians and researchers gathered last month at the American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO GU) — some in-person in San Francisco, some tuning in virtually. Hundreds of presentations covered advances in screening, diagnosis, treatment, monitoring, and survivorship in prostate and other GU. Read More
03/08/2022
Less Meat, Less Prostate Cancer?
People often have questions about whether specific foods—such as meat—might increase their risk of prostate cancer or other diseases. A new study of more than 200,000 men in the U.K. found that men who were vegetarian, and men who ate fish (but no meat), were less likely to be diagnosed. Read More
03/01/2022
DIY Home Fitness: Work with What You Have, Start Small, and Do Great Things
Many people start an exercise program with the idea, “Go big or go home.” They set overambitious goals, or start out trying to do too much, too fast, and they quit after a few weeks. You don’t have to do that, says PCF-funded Harvard scientist Christina Dieli-Conwright, Ph.D., M.P.H. If. Read More
02/23/2022
Focus on Disparities Research in Prostate Cancer
During Black History Month, we honor and celebrate the contributions of Black people in art, science, politics, and many other areas. As the theme of Black History Month this year is Black Health & Wellness, it is an opportunity to raise awareness of efforts to combat systemic racism and reduce. Read More
“Protein Style” Tempeh Burger
Download the recipe card If you live in proximity to the fast food restaurant In-N-Out, you’ve probably heard the lore of the secret menu, that is, the off-menu items that only those “in the know” can order. One such trick is to order your burger “protein style,” i.e., without the. Read More
02/15/2022
Bipolar Androgen Therapy and the Immune System
Some men are exceptional responders to Bipolar Androgen Therapy (BAT). Its pioneer, medical oncologist Samuel Denmeade, M.D., Co-Director of the Johns Hopkins Prostate Cancer Program, has a few patients who have remained on BAT alone for several years. But for many men, the response is temporary; just a few months. . Read More
02/08/2022
Know Your Risk. Be Your Own Advocate.
Matt Fish, a 47-year-old Veteran, has an important message for younger men. Know your history and risk factors for prostate cancer: if you’re over age 50, if you’re Black, or have a family history of cancer. Matt adds to that: if you’ve served in the military. And if you’re concerned,. Read More
02/03/2022
Statement From PCF CEO Charles J. Ryan, MD on the Relaunch of the “Cancer Moonshot”
President Biden has announced the bold and ambitious relaunch of the “Cancer Moonshot” initiative, aiming to reduce the death rate from cancer by 50 percent in the next 25 years. The Prostate Cancer Foundation (PCF) applauds this “all-hands-on-deck” approach to mobilize foundations, patient organizations, healthcare providers, and all Americans to. Read More
02/02/2022
How Bipolar Androgen Therapy Works
How BAT Works Several years ago, medical oncologist Samuel Denmeade, M.D., Co-Director of the Johns Hopkins Prostate Cancer Program, and colleagues came up with a remarkable concept for attacking prostate cancer: alternating ADT with high-dose testosterone. Patients have asked Denmeade if this treatment, called Bipolar Androgen Therapy (BAT), could be. Read More